TSLL is Telsa with a boost of steroids LONG
Updated
TSLL is an ETF of TESLA instruments leveraged 50% - while TSLA has its own range
percent from its volatility TSLL does this even more at a lower per share price.
On the 4H chart, TSLL can be seen pivoting down in a VWAP breakdown from a high
about July 19th. It is now in deep oversold territory supported by the redline of the
second standard deviation line below the thick black mean VWAP. On the ZL-MACD,
the cross under the histogram and the ascent of the lines toward the zero line shows
in my opinion bullish disvergence. Upside to the target just below the POC line of
the volume profile is about 15%. I will go long taking call options as :
1. contracts striking $ 16.00 for an expiration of 8/25 and,
2. contracts striking $ 17.00 for an expiration of 9/1.
I am anticipating overall profits of 100% as a goal in this trade. I avoid time decay
and in risk management I will close a position when it hits 100% or not less than
two days before the expiration. Good luck on this trade if you take it. DYODD !
percent from its volatility TSLL does this even more at a lower per share price.
On the 4H chart, TSLL can be seen pivoting down in a VWAP breakdown from a high
about July 19th. It is now in deep oversold territory supported by the redline of the
second standard deviation line below the thick black mean VWAP. On the ZL-MACD,
the cross under the histogram and the ascent of the lines toward the zero line shows
in my opinion bullish disvergence. Upside to the target just below the POC line of
the volume profile is about 15%. I will go long taking call options as :
1. contracts striking $ 16.00 for an expiration of 8/25 and,
2. contracts striking $ 17.00 for an expiration of 9/1.
I am anticipating overall profits of 100% as a goal in this trade. I avoid time decay
and in risk management I will close a position when it hits 100% or not less than
two days before the expiration. Good luck on this trade if you take it. DYODD !
Trade active
New Long Trade 
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.